Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
暂无分享,去创建一个
C. Bloomfield | J. Byrd | K. Mrózek | J. Kolitz | R. Stone | J. Blachly | D. Lucas | W. Blum | B. Bhatnagar | D. Nicolet | J. Kohlschmidt | Ann-Kathrin Eisfeld | S. Orwick | R. Stone | Clara D. Bloomfield